Genetics of AMKD getting deeper…
bit.ly/48PB2xk (FREE)
Genetics of AMKD getting deeper…
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
The US FDA approves Sibeprenlimab aka Voyxact for reducing proteinuria in IgA
www.fda.gov/drugs/novel-...
#NephSky
#TopNephrology
The US FDA approves Sibeprenlimab aka Voyxact for reducing proteinuria in IgA
www.fda.gov/drugs/novel-...
#NephSky
#TopNephrology
Look at the mortality in younger females (versus males) in CKD 5
jamanetwork.com/journals/jam... in @jamainternalmed.com from Alberta
#NephSky #GenderDisparities
Look at the mortality in younger females (versus males) in CKD 5
jamanetwork.com/journals/jam... in @jamainternalmed.com from Alberta
#NephSky #GenderDisparities
⚡ SGLT2 inhibitors, first made for glucose control, surprised us with strong renal + CV protection 💥 Their small, reversible eGFR dip (like RASi) hinted at the mechanism: more Na⁺ to the macula densa → restored tubuloglomerular feedback → ⬇️ glomerular pressure → nephroprotection. 🧬
⚡ SGLT2 inhibitors, first made for glucose control, surprised us with strong renal + CV protection 💥 Their small, reversible eGFR dip (like RASi) hinted at the mechanism: more Na⁺ to the macula densa → restored tubuloglomerular feedback → ⬇️ glomerular pressure → nephroprotection. 🧬
PISCES, the use of fish oil to decrease mortality in dialysis patients.
www.pubmed.ncbi.nlm....
PISCES, the use of fish oil to decrease mortality in dialysis patients.
www.pubmed.ncbi.nlm....
www.nephjc.com/freelyfilter...
With pinch hitters Brian Rifkin and Anna Gaddy
www.nephjc.com/freelyfilter...
With pinch hitters Brian Rifkin and Anna Gaddy
www.nephjc.com/news/atacice...
Excellent fast work from @notjustdialysis.bsky.social and @salinesolut.bsky.social
Atacicept in IgAN
www.nephjc.com/news/atacice...
Excellent fast work from @notjustdialysis.bsky.social and @salinesolut.bsky.social
Atacicept in IgAN
Application here
form.jotform.com/252084341700...
Application here
form.jotform.com/252084341700...
academic.oup.com/ndt/advance-...
in @ndt-era.bsky.social
It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru...
#PDSky #NephSky
academic.oup.com/ndt/advance-...
in @ndt-era.bsky.social
It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru...
#PDSky #NephSky
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
www.ajkd.org/article/S027...
In @ajkd.bsky.social
Sure it’s a risk factor for graft failure - but so is DM, CAD - which are worse and those are not contraindications!
#NephSky #Transplant
www.ajkd.org/article/S027...
In @ajkd.bsky.social
Sure it’s a risk factor for graft failure - but so is DM, CAD - which are worse and those are not contraindications!
#NephSky #Transplant
https://www.newsbeep.com/241229/
A world-first South Auckland dialysis model is being praised for saving lives, restoring dignity, and easing pressure on…
@asnkidney.bsky.social | #KidneyWk
@asnkidney.bsky.social | #KidneyWk
jamanetwork.com/journals/jam...
in @jama.com from #KidneyWk
Like STARRT-AKi et al, at the other end? Small trial - needs replication or this is common sense?
jamanetwork.com/journals/jam...
in @jama.com from #KidneyWk
Like STARRT-AKi et al, at the other end? Small trial - needs replication or this is common sense?
CDK 4/6
BRAF
EGFR
VEGF
and other cancer treatments
#OncoNephrology #NephSky #KidneyWk
jamanetwork.com/journals/jam... from Shuchi Anand et al from @stanfordmedicine.bsky.social
CDK 4/6
BRAF
EGFR
VEGF
and other cancer treatments
#OncoNephrology #NephSky #KidneyWk
jamanetwork.com/journals/jam... from Shuchi Anand et al from @stanfordmedicine.bsky.social
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Variants in type IV collagen cause a wide spectrum of disease. #KidneyWk 🧵
Variants in type IV collagen cause a wide spectrum of disease. #KidneyWk 🧵
@asnkidney.bsky.social | #KidneyWk
@asnkidney.bsky.social | #KidneyWk